Private Capital Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Private Capital Group’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-270	Closed	-$21K	–	2142
2021 Q1	$21K	Buy	270 +61	+29%	+$5.62K	0.01%	1039
2020 Q4	$21K	Sell	209 -27	-11%	-$3.3K	﹤0.01%	1159
2020 Q3	$33K	Buy	236 +11	+5%	+$1.83K	0.01%	893
2020 Q2	$44K	Hold	225	–	–	0.01%	778
2020 Q1	$44K	Sell	225 -66	-23%	-$14.2K	0.01%	701
2019 Q4	$60K	Buy	291 +44	+18%	+$8.13K	0.01%	644
2019 Q3	$38K	Buy	247 +228	+1,200%	+$37.4K	0.01%	898
2019 Q2	$2K	Buy	19 +13	+217%	+$1.54K	﹤0.01%	1897
2019 Q1	$1K	Sell	6 -13	-68%	-$1.31K	﹤0.01%	2028
2018 Q4	$2K	Hold	19	–	–	﹤0.01%	1866
2018 Q3	$2K	Hold	19	–	–	﹤0.01%	1944
2018 Q2	$1K	Sell	19 -75	-80%	-$7.28K	﹤0.01%	2006
2018 Q1	$9K	Sell	94 -1,126	-92%	-$121K	﹤0.01%	1411
2017 Q4	$9	Buy	+1,220	New	+$115K	﹤0.01%	1414

Other funds holding LKFT

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Private Capital Group's LKFT Position: Q2 2021 in Review

Private Capital Group sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2021, closing a stake of 270 shares — an estimated $21K sold.

Private Capital Group first reported a position in LKFT in Q4 2017 and held it in 14 quarters. The position peaked at $60K in Q4 2019. 108 funds tracked by Wall St. Rank hold LKFT as of Q2 2021.

Private Capital Group reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Private Capital Group sold 270 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2021, an estimated $21K.
Private Capital Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2017 and held it in 14 quarters.
Private Capital Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $60K in Q4 2019.
108 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2021.

Based on Private Capital Group's 13F filing for Q2 2021, filed 26 Jul 2021.